Centiva Capital, LP Viatris Inc Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Viatris Inc stock. As of the latest transaction made, Centiva Capital, LP holds 51,724 shares of VTRS stock, worth $652,756. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,724

Holding current value

$652,756

% of portfolio

0.01%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $533,791 - $627,412	51,724 New	51,724 $600,000
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $174,931 - $207,035	18,241 New	18,241 $179,000
Q2 2022 Aug 17, 2022	SELL	$9.95 - $12.27 $994,999 - $1.23 Million	-100,000 Reduced 59.05%	69,362 $726,000
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $690,151 - $851,071	69,362 Added 69.36%	169,362 $1.77 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $981,000 - $1.54 Million	100,000 New	100,000 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $453,121 - $550,191	-37,479 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $55,133 - $62,955	-4,161 Reduced 9.99%	37,479 $508,000
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $540,070 - $672,485	41,640 New	41,640 $595,000

Others Institutions Holding VTRS

# of Institutions

1,099

Shares Held

930M

Call Options Held

2.68M

Put Options Held

2.24M

Vanguard Group Inc Valley Forge, PA

141M
Shares

$1.78 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

92.7M
Shares

$1.17 Billion
0.02% of portfolio
State Street Corp Boston, MA

63.1M
Shares

$797 Million
0.03% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

62.6M
Shares

$791 Million
4.18% of portfolio
Price T Rowe Associates Inc Baltimore, MD

48.8M
Shares

$616 Million
0.07% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.3B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account